Safety, efficacy, and pharmacokinetics of vedolizumab in patients with simultaneous exposure to an anti-TNF

Authors
Category Primary study
JournalJournal of Crohn's and Colitis
Year 2018
This article has no abstract
Epistemonikos ID: 0c0d48c23653409ba95b5a3fe41f9e63e8d1a2c9
First added on: Feb 09, 2025